Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 23% ± 5% | |
epithelial cell | 6 studies | 25% ± 8% | |
glutamatergic neuron | 5 studies | 36% ± 19% | |
ciliated cell | 5 studies | 26% ± 8% | |
natural killer cell | 4 studies | 20% ± 3% | |
astrocyte | 4 studies | 37% ± 15% | |
GABAergic neuron | 3 studies | 42% ± 10% | |
dendritic cell | 3 studies | 21% ± 2% | |
neuron | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2930.67 | 1445 / 1445 | 100% | 24.74 | 183 / 183 |
lung | 100% | 3146.44 | 578 / 578 | 100% | 27.94 | 1155 / 1155 |
ovary | 100% | 2822.37 | 180 / 180 | 100% | 32.42 | 430 / 430 |
stomach | 100% | 2753.13 | 359 / 359 | 100% | 29.85 | 286 / 286 |
prostate | 100% | 2877.34 | 245 / 245 | 100% | 26.50 | 501 / 502 |
skin | 100% | 3477.47 | 1809 / 1809 | 100% | 33.54 | 471 / 472 |
intestine | 100% | 3088.21 | 966 / 966 | 100% | 31.05 | 525 / 527 |
breast | 100% | 2915.37 | 459 / 459 | 100% | 28.22 | 1113 / 1118 |
brain | 100% | 2977.58 | 2629 / 2642 | 100% | 35.46 | 704 / 705 |
thymus | 100% | 3184.80 | 653 / 653 | 99% | 31.96 | 601 / 605 |
bladder | 100% | 2915.05 | 21 / 21 | 99% | 29.65 | 499 / 504 |
kidney | 100% | 2796.90 | 89 / 89 | 99% | 21.97 | 890 / 901 |
pancreas | 100% | 1466.55 | 327 / 328 | 99% | 27.56 | 176 / 178 |
uterus | 100% | 3654.45 | 170 / 170 | 98% | 33.14 | 452 / 459 |
adrenal gland | 100% | 3768.69 | 258 / 258 | 97% | 33.01 | 224 / 230 |
liver | 100% | 1828.91 | 226 / 226 | 96% | 18.38 | 389 / 406 |
adipose | 100% | 2842.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3362.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 31.07 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 28.76 | 29 / 29 |
muscle | 100% | 3273.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3842.85 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.54 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.99 | 1 / 1 |
heart | 98% | 3447.83 | 845 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 70% | 1551.71 | 653 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0043278 | Biological process | response to morphine |
GO_0000278 | Biological process | mitotic cell cycle |
GO_0000165 | Biological process | MAPK cascade |
GO_0006302 | Biological process | double-strand break repair |
GO_0010288 | Biological process | response to lead ion |
GO_0035970 | Biological process | peptidyl-threonine dephosphorylation |
GO_1904550 | Biological process | response to arachidonic acid |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0070262 | Biological process | peptidyl-serine dephosphorylation |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0005886 | Cellular component | plasma membrane |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0101031 | Cellular component | protein folding chaperone complex |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0043531 | Molecular function | ADP binding |
GO_0004721 | Molecular function | phosphoprotein phosphatase activity |
GO_0008289 | Molecular function | lipid binding |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
GO_0048156 | Molecular function | tau protein binding |
GO_0016791 | Molecular function | phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PPP5C |
Protein name | Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT) Serine/threonine-protein phosphatase (EC 3.1.3.16) |
Synonyms | PPP5 |
Description | FUNCTION: Serine/threonine-protein phosphatase that dephosphorylates a myriad of proteins involved in different signaling pathways including the kinases CSNK1E, ASK1/MAP3K5, PRKDC and RAF1, the nuclear receptors NR3C1, PPARG, ESR1 and ESR2, SMAD proteins and TAU/MAPT . Implicated in wide ranging cellular processes, including apoptosis, differentiation, DNA damage response, cell survival, regulation of ion channels or circadian rhythms, in response to steroid and thyroid hormones, calcium, fatty acids, TGF-beta as well as oxidative and genotoxic stresses . Participates in the control of DNA damage response mechanisms such as checkpoint activation and DNA damage repair through, for instance, the regulation ATM/ATR-signaling and dephosphorylation of PRKDC and TP53BP1 . Inhibits ASK1/MAP3K5-mediated apoptosis induced by oxidative stress . Plays a positive role in adipogenesis, mainly through the dephosphorylation and activation of PPARG transactivation function (By similarity). Also dephosphorylates and inhibits the anti-adipogenic effect of NR3C1 (By similarity). Regulates the circadian rhythms, through the dephosphorylation and activation of CSNK1E . May modulate TGF-beta signaling pathway by the regulation of SMAD3 phosphorylation and protein expression levels . Dephosphorylates and may play a role in the regulation of TAU/MAPT . Through their dephosphorylation, may play a role in the regulation of ions channels such as KCNH2 (By similarity). Dephosphorylate FNIP1, disrupting interaction with HSP90AA1/Hsp90 . . |
Accessions | Q9BPW0 ENST00000391919.1 A8MU39 ENST00000012443.9 H0YDU8 P53041 ENST00000478046.5 |